IP Library Assignment 075778/0924
Patent Assignment
Reel/Frame 075778/0924

Assignment of Assignor's Interest

Recorded: 2026-05-06 Pages: 26
Assignor
Assignee
AXSOME THERAPEUTICS, INC.
ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NEW YORK, 10007
Covered Properties (28)
Pyridazinone compound
Application: 61/202,207 →
Pyridazinone compound
Application: 61/213,927 →
Pyridazinone Compounds as Phosphodiesterase Inhibitors and Methods of Treating Disorders
Application: 15/377,149 →
Publication: US US20170114044A1
Pyridazinone Compounds as Phosphodiesterase Inhibitors and Methods of Treating Disorders
Patent: 8,916,566 →
Application: 12/656,605 →
Publication: US US20100197651A1
1-Phenyl-3-Pyrazolylpyridazin-4(1H)-One Compound
Patent: 8,354,411 →
Application: 13/148,172 →
Publication: US US20120028951A1
Pyridazinone Compounds as Phosphodiesterase Inhibitors and Methods of Treating Disorders
Patent: 9,550,756 →
Application: 14/517,313 →
Publication: US US20150099757A1
Pyridazinone Compounds
Patent: 8,435,995 →
Application: 13/543,332 →
Publication: US US20120277431A1
Pyridazinone Compounds
Patent: 8,513,251 →
Application: 13/543,296 →
Publication: US US20120277430A1
Pyridazinone Compounds
Patent: 8,778,944 →
Application: 13/543,207 →
Publication: US US20120277204A1
Production Method of Pyridazinone Compounds
Application: 14/768,784 →
Publication: US US20160002209A1
Balipodect for Treating or Preventing Autism Spectrum Disorders
Application: 17/280,371 →
Publication: US US20210379061A1
Balipodect for Treating or Preventing Autism Spectrum Disorders
Application: 19/226,629 →
Publication: US US20250288581A1
Solid Dispersion
Application: 15/126,334 →
Publication: US US20170079915A1
Fused Heterocyclic Compounds
Application: 61/358,121 →
Fused Heterocyclic Compounds
Application: 61/422,845 →
Fused Heterocyclic Compounds
Patent: 8,563,575 →
Application: 13/166,212 →
Publication: US US20110319394A1
Fused Heterocyclic Compounds as Phosphodiesterases (Pdes) Inhibitors
Patent: 8,846,713 →
Application: 13/806,352 →
Publication: US US20130172328A1
Fused Heterocyclic Compounds
Patent: 8,940,758 →
Application: 13/944,370 →
Publication: US US20130303553A1
Fused Heterocyclic Compounds as Phosphodiesterases (Pdes) Inhibitors
Patent: 9,226,921 →
Application: 14/253,139 →
Publication: US US20140228320A1
Crystal of Fused Heterocyclic Compound
Patent: 9,512,118 →
Application: 14/125,390 →
Publication: US US20140113932A1
Radiolabeled Compounds and Their Use as Radiotracers for Quantitative Imaging of Phosphodiesterase (PDE10A) in Mammals
Patent: 9,579,407 →
Application: 14/237,234 →
Publication: US US20140178304A1
Fused Heterocyclic Ring Compound
Patent: 8,883,788 →
Application: 13/814,035 →
Publication: US US20130137700A1
Heterocyclic Compound
Patent: 9,090,586 →
Application: 13/813,786 →
Publication: US US20130150344A1
Substituted Pyridazin-4(1H)-Ones as Phosphodiesterase 10A Inhibitors
Patent: 9,150,588 →
Application: 13/816,011 →
Publication: US US20130137675A1
Fused Heterocyclic Compounds
Application: 61/370,566 →
Fused Heterocyclic Compounds
Application: 61/427,271 →
Fused Heterocyclic Compounds
Patent: 9,029,536 →
Application: 13/814,073 →
Publication: US US20130172292A1
Condensed Heterocyclic Compound
Patent: 9,029,388 →
Application: 14/002,439 →
Publication: US US20130331409A1
Related Assignments (10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 2, 2010
From: TANIGUCHI, TAKAHIKO; KAWADA, AKIRA; KONDO, MITSUYO; QUINN, JOHN F.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 024179/0436 →
Assignment of Assignor's Interest Sep 7, 2011
From: TANIGUCHI, TAKAHIKO; YOSHIKAWA, MASATO; MIURA, KASEI; HASUI, TOMOAKI
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 026865/0981 →
Assignment of Assignor's Interest Oct 20, 2011
From: TANIGUCHI, TAKAHIKO; KAWADA, AKIRA; KONDO, MITSUYO; QUINN, JOHN F.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 027092/0835 →
Assignment of Assignor's Interest Mar 7, 2013
From: TANIGUCHI, TAKAHIKO; YOSHIKAWA, MASATO; MIURA, KASEI; HASUI, TOMOAKI
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 029939/0293 →
Assignment of Assignor's Interest Dec 11, 2013
From: YAMAMOTO, KATSUHIKO
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 031759/0261 →
Assignment of Assignor's Interest Feb 5, 2014
From: TANIGUCHI, TAKAHIKO; MIURA, SHOTARO; HASUI, TOMOAKI; HALLDIN, CHRISTER
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 032146/0854 →
Assignment of Assignor's Interest Sep 30, 2015
From: FUKUDA, NAOHIRO; IKEMOTO, TOMOMI
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 036687/0969 →
Assignment of Assignor's Interest Sep 15, 2016
From: NOMURA, YUKIHIRO; TSUSHIMA, YUKI; EBISAWA, YUTAKA
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 039757/0290 →
Assignment of Assignor's Interest Jan 27, 2022
From: MAKHIJA, MAHINDRA
To: TAKEDA PHARMACEUTICALS INTERNATIONAL AG
Reel/Frame 058794/0534 →
Assignment of Assignor's Interest Feb 1, 2022
From: TAKEDA PHARMACEUTICALS INTERNATIONAL AG
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 058848/0699 →